TerminatedNot Applicable

Home-Based Technologies Coupled to Teleassistance Service in the Elderly

Stopped: Recruitment difficulties

France27 participantsStarted 2012-10

Plain-language summary

The growth of the elderly population is associated with the autonomy failure and the increase of dependence problems. Fall incidents are the third cause of chronic disablement in older persons and are one of the major risk factors for entering in dependence. The recent progress in home technologies and medical care are opportunities to search how to apply these tools to reduce and prevent falling at home. The purpose of this study is to evaluate the cost effectiveness of simple home automation pack coupled to teleassistance service for preventing home falls in frail elderly population. 1200 patients will be enrolled and randmosied within two arms: * home with automation pack coupled to teleassistance service * home without this technology

Who can participate

Age range

65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient aged 65 or over * Living at least for 1 year in the department of Creuse * Frail elderly or pre-frail according to the criteria of Fried * Patient with autonomy enough to get out of bed * Having a cognitive level acceptable (MMS ≥ 10) * Place of life arranged and adapted to the installation of the DSTA * Consentbsigned by the patient and / or its trusted person or his legal representative * Affiliation or beneficiary of a social security system Exclusion Criteria: * Patient under guardianship or protection of justice * patient home already equiped with automation pack different from theone of the experiment * People who can not read or write * Diseases involving life-threatening in the short term (\<1 year)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

incidence of home falls requiring emergency admission

Timeframe: at 12 months

Trial details

NCT IDNCT01697553

SponsorUniversity Hospital, Limoges

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-10-26

View on ClinicalTrials.gov More Disablement in the Elderly trials